Pnc Financial Services Group, Inc. Travere Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 20 shares of TVTX stock, worth $380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 20
-0.0%
Holding current value
$380
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TVTX
# of Institutions
194Shares Held
84.6MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$145 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$145 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$131 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$89 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$82.5 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.22B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...